MDT earnings: next report 2026-09-01, real EPS beat/miss history, analyst consensus Buy, P/E 21.84. Updated 2026-07-23.
Medtronic (MDT) Research Hub
Medtronic (MDT) trades on NYSE, IE in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 90.96 USD (-1.01%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 21.84, market cap 104.77B. This hub links to the full technical, earnings and options research available for MDT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, IE |
| Last close | 90.96 USD (-1.01%) |
| 52-week range | 77.62 USD – 95.41 USD |
| Trend regime | Range |
| 14-day RSI | 60.6 (Bullish) |
| Trailing P/E | 21.84 |
| Market cap | 104.77B |
| Dividend yield | 3.48% |
| Next earnings | 2026-09-01 |
Available research for MDT
Covered Call on MDT: how it works, illustrative setup around the real 90.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MDT: how it works, illustrative setup around the real 90.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MDT: how it works, illustrative setup around the real 90.96 USD price, max profit/loss, breakeven and when to use it. Educational.
MDT technical analysis: range, last 90.96 USD, RSI 60.6, 52w range 77.62 USD–95.41 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MDT in?
Medtronic (MDT) is classified under Healthcare (Medical - Devices), listed on NYSE, IE.
Is MDT in an uptrend or downtrend?
As of 2026-09-11, MDT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MDT's trailing P/E ratio?
MDT's trailing P/E is 21.84, with a market cap of 104.77B. See the earnings research page for full valuation detail.
When does MDT next report earnings?
MDT is next scheduled to report earnings on 2026-09-01, with a consensus EPS estimate of 1.39 USD.